A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes
LUAD can be classified into three subtypes according to COMAR genes, which may provide guidance for precise treatment.
Authors
- Yuan Tian (ORCID: https://orcid.org/0000-0002-2296-1246)
- Wen Xiao (ORCID: https://orcid.org/0000-0001-6559-3036)
- Ling Chen (ORCID: https://orcid.org/0000-0003-1485-1626)
- Hongtao Liu (ORCID: https://orcid.org/0000-0002-6585-9954)
- Fujing Huang
- Zhuoqi Li (ORCID: https://orcid.org/0000-0001-9396-4850)
- Lu Zhang (ORCID: https://orcid.org/0009-0004-0981-995X)
- Zhigang Wei
Institutions
- Qingdao University (CN)
- Qingdao Municipal Hospital (CN)
- Shandong Provincial QianFoShan Hospital (CN)
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-13
- DOI
- https://doi.org/10.3389/fimmu.2025.1518102
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56